Linking preclinical mechanisms of neurodegeneration to individual risk profiles of Alzheimer's disease
Linking preclinical mechanisms of neurodegeneration to individual risk profiles of Alzheimer's disease
批准号:
435889
负责人:
Schmitz Taylor W
金额:
$76.07万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
未结题
起止时间:
2020-10-01 至 2025-10-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Alzheimer's disease (AD) is one of the largest impending healthcare policy crises worldwide. An estimated 564,000 Canadians currently live with dementia. By 2031, this figure will increase by 66%. For many diseases with age as a primary risk factor, such
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Leveraging deep biology for brain resilience to AD pathology
-
批准号:486679
-
项目类别:Operating Grants
-
资助金额:$53.88万
-
财政年份:2023
-
负责人:Schmitz Taylor W
-
依托单位:
A non-invasive preclinical biomarker of neurodegeneration in Alzheimer's and related demnentias
-
批准号:448635
-
项目类别:Operating Grants
-
资助金额:$7.22万
-
财政年份:2020
-
负责人:Schmitz Taylor W
-
依托单位:
海外基金